February 13, 2018 / 9:24 PM / in 4 months

BRIEF-Bioverativ Q4 Revenue Rose 28.3 Percent To $328.7 Million

Reuters Staff

1 Min Read

* BIOVERATIV REPORTS FOURTH QUARTER AND FULL YEAR 2017 PERFORMANCE

* Q4 REVENUE ROSE 28.3 PERCENT TO $328.7 MILLION

* QTRLY ‍SHR $1.30 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below